𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to “Residual tumor after neoadjuvant chemotherapy and interval debulking for advanced endometrial cancer”

✍ Scribed by Lisa M. Landrum; D. Scott McMeekin

Book ID
113962056
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
93 KB
Volume
114
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MRI evaluation of pathologically complet
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
✍ Jeon Hor Chen; Byon Feig; Garima Agrawal; Hon Yu; Philip M. Carpenter; Rita S. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

## Abstract ## BACKGROUND. This study investigated the role of magnetic resonance imaging (MRI) in evaluation of pathologically complete response and residual tumors in patients who were receiving neoadjuvant chemotherapy (NAC) for both positive and negative HER‐2 breast cancer. ## METHODS. Fift

Residual tumor uptake of [99mTc]-sestami
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival
✍ Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Robert B. Livingston; Han 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract ## BACKGROUND Studies utilizing serial [^99m^Tc]‐sestamibi (MIBI) scintimammography have reported accurate prediction of tumor response in patients with locally advanced breast carcinoma (LABC) undergoing neoadjuvant chemotherapy. The pathologic response of LABC to presurgical treatmen